SMARCB1 and nasal cavity and paranasal sinus carcinoma: A comprehensive targeted next-generation sequencing study on a relatively large cohort of the SMARCB1-deficient sinonasal carcinoma (n = 22) revealed the loss of at least one SMARCB1 allele, with most cases (13/19, 68%) showing homozygous deletion [21].